the strong risk aversion at the FDA is creating at least the perception that it is slowing down or stopping the approval of new, innovative treatments for cancer and other life-threatening terminal diseases.
Expressing concern about FDA's risk aversion impacting treatment approvals.
Share
More from Joe Pitts
It seems illogical that the USDA would be given the exclusive authority to oversee and regulate catfish only while the FDA regulates all other seafood.
The goals of the ACE Kids Act are laudable--to improve the delivery of, access to, healthcare for children with complex medical conditions served by Medicaid.
Today's hearing is an important discussion that will examine the areas where we can improve our national trauma system.
Other voices in this conversation
